Susan Hasty, Publisher
Table of Contents . . . October 15th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in AIDS Weekly | Other Publications
HIV Resistance - Mutations Causing Partial CCR5 Dysfunction Still Confer Protection
HIV Vaccine - Differences In Infection Routes May Complicate Development
AIDS Therapies - Adefovir Has Limited Effect On Drug Resistance Risk
AIDS Therapies - HIV Patients More Likely To Accept Drug Regimens If They Trust Physicians
HIV Vaccine - Plasmid DNA Delivery Of Attenuated Virus Inefficient
AIDS Therapies - Scientists Identify New Drug Targets For HIV Infection
AIDS Therapies - Three New Patents Covering HIV Immunotherapeutic Agents Issued
AIDS Therapy - Drug Abusers Often Do Not Initiate Antiretroviral Therapy
AIDS/HIV Tuberculosis - Italian Prevention Guidelines Effective, But Underused
Cervical Cancer - Regulator Evaluated In HIV Infected Women
Drug Development - Antiviral Peptides Potentially Useful Against STDs
Drug Development - Researchers Investigate Effectiveness Of Microbicides Against HIV
Functional Genomics - Novel Means For Stopping Gene Transcription Found
HIV Reporting - GRI Gets Nearly $1 Million From Gates Foundation
Muscle Wasting - Atrix Acquires Novel Growth Promoting Peptide
Research - Integrase Test Accelerates Screening For Potential New AIDS Drugs
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.